Connection lost
Server error
Eli Lilly and Co. v. Emisphere Technologies, Inc. Case Brief
Why Top Law Students (And Those Aspiring to Be) Use LSD+ Briefs
Let's be real, law school is a marathon. Our exclusive Flash-to-Full case system is designed by Harvard Law School and MIT grads to match your pace: Quick summaries when you're slammed, detailed analysis when you need to go deep. Only LSD+ offers this kind of flexibility to genuinely fit your study flow.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: A pharmaceutical company secretly used its partner’s proprietary drug-delivery technology for research outside their licensed agreement. The court found this constituted a material, incurable breach of contract, destroying the trust essential to the collaboration and justifying the partner’s termination of the agreements.
Legal Significance: This case establishes that exceeding a field-of-use restriction in a technology collaboration agreement can be a material breach of contract, not merely patent infringement, especially when the license involves the transfer of extensive know-how and confidential information.
Eli Lilly and Co. v. Emisphere Technologies, Inc. Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
Eli Lilly and Company (Lilly) and Emisphere Technologies, Inc. (Emisphere) entered into a series of contracts for a collaborative research program to develop an oral delivery system for parathyroid hormone (PTH). The PTH License Agreement granted Lilly an exclusive license to use Emisphere’s proprietary carrier technology solely within the defined “Field” of oral PTH delivery. Section 2.1 of that agreement explicitly stated, “Lilly shall not have any rights to use the Emisphere Technology… other than insofar as they relate directly to the Field.” The agreements also contained strict confidentiality provisions (§ 11.2) and a clause assigning ownership to Emisphere of any new inventions arising from discussions between the parties’ scientists (RCOA II § 1.5(c)). While the collaboration was ongoing, Lilly secretly formed an internal team, led by the same manager overseeing the joint project, to research the use of Emisphere’s carriers with other proteins, specifically GLP-1. A key scientist from the joint project briefed this secret team, sharing non-public and confidential information from the Emisphere collaboration. Lilly subsequently filed a patent application for its GLP-1 research. Upon discovering the patent application, Emisphere alleged breach and, after failed negotiations, terminated the agreements.
Court Holding & Legal Precedent
Issue: Did Lilly’s secret, independent research using Emisphere’s proprietary technology for applications outside the contractually defined field of collaboration constitute a material breach of the parties’ agreements, thereby entitling Emisphere to terminate the contracts?
Yes. Lilly committed multiple, material, and incurable breaches of the agreements by Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
IRAC Legal Analysis
Complete IRAC Analysis for Higher Grades
IRAC (Issue, Rule, Analysis, Conclusion) is the exact format professors want to see in your exam answers. Our exclusive Flash-to-Full briefs combine holding, analysis, and rule statements formatted to match what A+ students produce in exams. These structured briefs help reinforce the essential legal reasoning patterns expected in law school.
Legal Issue
Did Lilly’s secret, independent research using Emisphere’s proprietary technology for applications outside the contractually defined field of collaboration constitute a material breach of the parties’ agreements, thereby entitling Emisphere to terminate the contracts?
Conclusion
This case provides a strong precedent for enforcing field-of-use and confidentiality clauses Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
Legal Rule
Under New York law, a material breach of contract is one that Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetu
Legal Analysis
The court found Lilly committed three distinct, material breaches. First, Lilly breached Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
Flash-to-Full Case Opinions
Flash Summary
- Eli Lilly breached its licensing agreement by secretly using Emisphere’s proprietary